Artivion | CRY - Gross Profit On Sales


Artivion reported $73.14M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 44.78M 2.93M Sep/2025
Artivion USD 73.14M 1.25M Dec/2025
AtriCure USD 109.31M 3.97M Mar/2026
Baxter International USD 891M 314M Mar/2026
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Boston Scientific USD 3.61B 64M Mar/2026
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Inogen USD 41.34M 1.39M Sep/2024
Integra LifeSciences USD 213.21M 3.89M Mar/2026
J&J USD 17.24B 642M Mar/2026
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 153.28M 4.76M Dec/2025
Pfizer USD 11.04B 1.24B Mar/2026
ResMed USD 890.98M 12.26M Mar/2026
Stryker USD 3.81B 675M Mar/2026
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.43M 21K Mar/2026
Terumo JPY 149.02B 4.17B Mar/2026
Trinity Biotech USD 6.47M 1.59M Sep/2025